| abstract |
The invention relates to a method of gene silencing, comprising administering to a cell or a subject in need thereof a therapeutically effective amount of the lipophilic moieties-conjugated double- stranded iRNAs at one or more internal positions on at least one strand, optionally via a linker or carrier. |